Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Anticipate generic drug launch
Find generic entry opportunities
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists|
|Abstract:||The invention relates to novel tetrahydro-1H-carbazole derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and methods of treatment comprising administration of said compounds to patients.|
|Inventor(s):||Fecher; Anja (Basel, CH), Fretz; Heinz (Riehen, CH), Riederer; Markus (Liestal, CH)|
|Assignee:||Actelion Pharmaceutical Ltd. (Allschwil, CH)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Use;|
Back Citations: 32nd percentile
Forward Citations: 0th percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Japan||2008525426||<disabled in preview>|
|Israel||184233||<disabled in preview>|
|Croatia||P20110773||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.